News & Insights

Explore the latest science, news, and updates from Blossom Innovations

Latest Updates

R2 Technologies Earns Third FDA Indication

San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.

Read More »

R2 Technologies Earns Third FDA Indication

San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.

Read More »

Latest Science

Onychomycosis nail fungus
Blossom Innovations

Nail Fungus: Embarrassing. Ugly. Dangerous.

Nail fungus, or onychomycosis, is a familiar problem that’s often seen as little more than an unsightly and hard to treat cosmetic issue. But for many of the millions of people worldwide who are affected by this under-treated condition, the impact may be far greater — and far more serious.

Read More >

Latest News

Blossom Innovations

R2 Technologies Earns Third FDA Indication

San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.

Read More >